Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码，获取更多信息
A multi-center randomized double-blind placebo-controlled trial of Xiongshao Capsule (芎芍胶囊) in preventing restenosis after percutaneous coronary intervention: A subgroup analysis of senile patients
  
View Full Text  View/Add Comment  Download reader
KeyWord:
Author NameAffiliationE-mail
Qing-hua Shang Beijing University of Chinese Medicine, Beijing, 100029, China  
Hao Xu National Integrative Medicine Center for Cardiovascular Diseases, China-Japan Friendship Hospital, Beijing, 100029, China xuhaotcm@gmail.com 
Xiao-yan Lu National Integrative Medicine Center for Cardiovascular Diseases, China-Japan Friendship Hospital, Beijing, 100029, China  
Chuan Wen National Integrative Medicine Center for Cardiovascular Diseases, China-Japan Friendship Hospital, Beijing, 100029, China  
Da-zhuo Shi Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China  
Ke-ji Chen Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, 100091, China chen.keji@gmail.com 
Hits: 974
Download times: 0
Abstract:
      

Objective  

To evaluate the safety and efficacy of Xiongshao Capsule (芎芍胶囊, XS), consisting of Chuangxiongol and paeoniflorin, in preventing restenosis after percutaneous coronary intervention (PCI) in senile coronary heart disease (CHD) patients.
Close
Copyright©2024 All rights reserved. Chinese Journal of Integrative Medicine
Address:1 Caochang, xiyuan, Beijing, People's Republic of China Post Code:100091 Telephone：010-62886827, 62877592 Fax:010-62874291
Supported by:Beijing Qin Yun Technology Development Co., Ltd.